

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | definitive hemopoiesis (GO:0060216) | 4.53001968 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 3.90469627 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90469627 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90469627 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90469627 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 3.90469627 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90469627 |
| 8 | phospholipid homeostasis (GO:0055091) | 3.87864296 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.70255857 |
| 10 | interkinetic nuclear migration (GO:0022027) | 3.64717009 |
| 11 | mannose metabolic process (GO:0006013) | 3.40654229 |
| 12 | negative regulation of granulocyte differentiation (GO:0030853) | 3.37899240 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33622976 |
| 14 | regulation of cholesterol storage (GO:0010885) | 3.31353732 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30164521 |
| 16 | regulation of sequestering of triglyceride (GO:0010889) | 3.29927428 |
| 17 | histone H3-K36 demethylation (GO:0070544) | 3.28922183 |
| 18 | cellular response to ethanol (GO:0071361) | 3.28492280 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.28459562 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 3.24867755 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.24141069 |
| 22 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.23274750 |
| 23 | carnitine shuttle (GO:0006853) | 3.20938372 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19123741 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.18168044 |
| 26 | regulation of cholesterol homeostasis (GO:2000188) | 3.16626293 |
| 27 | cellular response to exogenous dsRNA (GO:0071360) | 3.12791121 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.12684566 |
| 29 | valine metabolic process (GO:0006573) | 3.12201736 |
| 30 | desmosome organization (GO:0002934) | 3.11901806 |
| 31 | urea metabolic process (GO:0019627) | 3.09254022 |
| 32 | urea cycle (GO:0000050) | 3.09254022 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09182796 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07783909 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98784548 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 2.95820822 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95524941 |
| 38 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.94570131 |
| 39 | embryonic process involved in female pregnancy (GO:0060136) | 2.92910176 |
| 40 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.91457587 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84730700 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 2.83824774 |
| 43 | positive regulation of p38MAPK cascade (GO:1900745) | 2.82601845 |
| 44 | lysine metabolic process (GO:0006553) | 2.81993949 |
| 45 | lysine catabolic process (GO:0006554) | 2.81993949 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81798231 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81798231 |
| 48 | negative regulation of stress fiber assembly (GO:0051497) | 2.81449556 |
| 49 | complement activation, alternative pathway (GO:0006957) | 2.80856609 |
| 50 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.79491471 |
| 51 | positive regulation of lipid catabolic process (GO:0050996) | 2.77147611 |
| 52 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.74942812 |
| 53 | histone H3-K4 trimethylation (GO:0080182) | 2.74931463 |
| 54 | biotin metabolic process (GO:0006768) | 2.70540247 |
| 55 | positive regulation of protein deacetylation (GO:0090312) | 2.69474768 |
| 56 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.68463302 |
| 57 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.68166078 |
| 58 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.67178731 |
| 59 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.67126282 |
| 60 | homocysteine metabolic process (GO:0050667) | 2.66845568 |
| 61 | apoptotic cell clearance (GO:0043277) | 2.62408838 |
| 62 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.61911881 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 2.61689783 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 2.60931315 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59697278 |
| 66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.58714508 |
| 67 | protein carboxylation (GO:0018214) | 2.58714508 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 2.58191078 |
| 69 | low-density lipoprotein particle clearance (GO:0034383) | 2.58151925 |
| 70 | phospholipid efflux (GO:0033700) | 2.58012728 |
| 71 | carnitine transmembrane transport (GO:1902603) | 2.56667605 |
| 72 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.54745372 |
| 73 | lipoprotein transport (GO:0042953) | 2.54082875 |
| 74 | regulation of histone H3-K27 methylation (GO:0061085) | 2.50504338 |
| 75 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.50013851 |
| 76 | cellular extravasation (GO:0045123) | 2.49943349 |
| 77 | pre-miRNA processing (GO:0031054) | 2.49734339 |
| 78 | regulation of p38MAPK cascade (GO:1900744) | 2.45536417 |
| 79 | regulation of establishment of cell polarity (GO:2000114) | 2.44375616 |
| 80 | hepatocyte apoptotic process (GO:0097284) | 2.44274849 |
| 81 | regulation of granulocyte differentiation (GO:0030852) | 2.44206457 |
| 82 | regulation of protein activation cascade (GO:2000257) | 2.44007066 |
| 83 | regulation of triglyceride metabolic process (GO:0090207) | 2.43381153 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.43187042 |
| 85 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43013578 |
| 86 | establishment of skin barrier (GO:0061436) | 2.42344395 |
| 87 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.42309320 |
| 88 | response to host defenses (GO:0052200) | 2.42011212 |
| 89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42011212 |
| 90 | response to host (GO:0075136) | 2.42011212 |
| 91 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.41854366 |
| 92 | carnitine transport (GO:0015879) | 2.41394617 |
| 93 | amino-acid betaine transport (GO:0015838) | 2.41394617 |
| 94 | fatty acid beta-oxidation (GO:0006635) | 2.41329214 |
| 95 | detection of molecule of bacterial origin (GO:0032490) | 2.41144426 |
| 96 | regulation of fatty acid oxidation (GO:0046320) | 2.40492020 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 2.40296232 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 2.39048131 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39035194 |
| 100 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.38574336 |
| 101 | positive regulation of cholesterol efflux (GO:0010875) | 2.38405597 |
| 102 | response to host immune response (GO:0052572) | 2.37963503 |
| 103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.37963503 |
| 104 | positive regulation of cholesterol transport (GO:0032376) | 2.37755122 |
| 105 | positive regulation of sterol transport (GO:0032373) | 2.37755122 |
| 106 | histone H3-K4 methylation (GO:0051568) | 2.37195950 |
| 107 | pinocytosis (GO:0006907) | 2.36708272 |
| 108 | regulation of complement activation (GO:0030449) | 2.36593934 |
| 109 | positive regulation of lipid storage (GO:0010884) | 2.36111974 |
| 110 | B cell receptor signaling pathway (GO:0050853) | 2.35601049 |
| 111 | I-kappaB phosphorylation (GO:0007252) | 2.35510515 |
| 112 | positive regulation of chemokine secretion (GO:0090197) | 2.34977658 |
| 113 | protein-lipid complex assembly (GO:0065005) | 2.34672575 |
| 114 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.33568619 |
| 115 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.33046578 |
| 116 | intestinal epithelial cell development (GO:0060576) | 2.32108920 |
| 117 | striated muscle atrophy (GO:0014891) | 2.31813640 |
| 118 | negative regulation of phagocytosis (GO:0050765) | 2.31565638 |
| 119 | NLS-bearing protein import into nucleus (GO:0006607) | 2.31069889 |
| 120 | regulation of water loss via skin (GO:0033561) | 2.31035884 |
| 121 | kynurenine metabolic process (GO:0070189) | 2.30757441 |
| 122 | iron ion import (GO:0097286) | 2.30477937 |
| 123 | acylglycerol homeostasis (GO:0055090) | 2.30446085 |
| 124 | triglyceride homeostasis (GO:0070328) | 2.30446085 |
| 125 | cysteine metabolic process (GO:0006534) | 2.30131246 |
| 126 | cell-substrate junction assembly (GO:0007044) | 2.30093447 |
| 127 | sulfur amino acid catabolic process (GO:0000098) | 2.29808006 |
| 128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.28483214 |
| 129 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.28427210 |
| 130 | negative regulation of fatty acid transport (GO:2000192) | 2.27090609 |
| 131 | flavonoid metabolic process (GO:0009812) | 2.26175884 |
| 132 | regulation of integrin activation (GO:0033623) | 2.25331443 |
| 133 | peptidyl-lysine trimethylation (GO:0018023) | 2.24935325 |
| 134 | growth hormone receptor signaling pathway (GO:0060396) | 2.24391925 |
| 135 | embryonic hemopoiesis (GO:0035162) | 2.23452992 |
| 136 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.21897986 |
| 137 | peptidyl-lysine methylation (GO:0018022) | 2.20807485 |
| 138 | early endosome to late endosome transport (GO:0045022) | 2.20633315 |
| 139 | detection of other organism (GO:0098543) | 2.19232999 |
| 140 | negative regulation of interleukin-8 production (GO:0032717) | 2.19044554 |
| 141 | detection of bacterium (GO:0016045) | 2.18767140 |
| 142 | TOR signaling (GO:0031929) | 2.17457970 |
| 143 | germinal center formation (GO:0002467) | 2.17327313 |
| 144 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.16209132 |
| 145 | megakaryocyte development (GO:0035855) | 2.15272730 |
| 146 | positive thymic T cell selection (GO:0045059) | 2.14845839 |
| 147 | histone lysine demethylation (GO:0070076) | 2.14020901 |
| 148 | response to peptidoglycan (GO:0032494) | 2.12926775 |
| 149 | corticosteroid receptor signaling pathway (GO:0031958) | 2.12381664 |
| 150 | cellular response to growth hormone stimulus (GO:0071378) | 2.12309836 |
| 151 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.11548481 |
| 152 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.11491828 |
| 153 | histone lysine methylation (GO:0034968) | 2.11378465 |
| 154 | phospholipid translocation (GO:0045332) | 2.11347128 |
| 155 | lipid translocation (GO:0034204) | 2.11347128 |
| 156 | negative regulation of protein activation cascade (GO:2000258) | 2.11123633 |
| 157 | negative regulation of fibrinolysis (GO:0051918) | 2.10289499 |
| 158 | white fat cell differentiation (GO:0050872) | 2.09976588 |
| 159 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.09883865 |
| 160 | histone demethylation (GO:0016577) | 2.09075845 |
| 161 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.07517834 |
| 162 | regulation of germinal center formation (GO:0002634) | 2.06319162 |
| 163 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.05449680 |
| 164 | detection of external biotic stimulus (GO:0098581) | 2.05233368 |
| 165 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.04964124 |
| 166 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.04964124 |
| 167 | negative regulation of complement activation (GO:0045916) | 2.04643007 |
| 168 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.04327743 |
| 169 | positive regulation of mRNA catabolic process (GO:0061014) | 2.04291878 |
| 170 | trophectodermal cell differentiation (GO:0001829) | 2.04176649 |
| 171 | regulation of B cell differentiation (GO:0045577) | 2.03902760 |
| 172 | regulation of chemokine secretion (GO:0090196) | 2.03838343 |
| 173 | protein K48-linked deubiquitination (GO:0071108) | 2.01992783 |
| 174 | negative regulation of TOR signaling (GO:0032007) | 2.01514310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.13532114 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25544481 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.21225828 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.17857609 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.12982213 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.04965262 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.03747848 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88782771 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87912173 |
| 10 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70859479 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.59003134 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.48465076 |
| 13 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48420097 |
| 14 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.35735694 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26023415 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20283955 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11418588 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.02227809 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01113275 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98980625 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.97058363 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94520939 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94145518 |
| 24 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89347073 |
| 25 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86920193 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86696503 |
| 27 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79221577 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78124412 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.77911877 |
| 30 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77834045 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76504525 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75643183 |
| 33 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73313713 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73070297 |
| 35 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72387210 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71810679 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71614586 |
| 38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67826432 |
| 39 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67795230 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64319821 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63932539 |
| 42 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62850592 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62253147 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.62157295 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58452461 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.55810538 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55070270 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53833698 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51559588 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49312832 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49126713 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48858517 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48306182 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45819893 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44634299 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43088919 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43063270 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42794550 |
| 59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41808553 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41789377 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41485992 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40781876 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.37998374 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35112589 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.33700991 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30467683 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29832785 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29439738 |
| 69 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.27305034 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27112015 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24921961 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24774598 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24318274 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23473579 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23283659 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21977734 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21977734 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20188230 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19170324 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18822240 |
| 81 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18792854 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17153691 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17153691 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16127347 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15608538 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15179489 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14854133 |
| 88 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14373334 |
| 89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.14141313 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13964433 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13910228 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11485043 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10528807 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10167287 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09929633 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09926249 |
| 97 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09878714 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08318017 |
| 99 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08198247 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 1.07377574 |
| 101 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07117647 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06665123 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06285757 |
| 104 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05861420 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04403566 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04341796 |
| 107 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03158675 |
| 108 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01812484 |
| 109 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01611873 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01464544 |
| 111 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.01067145 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00764056 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00453616 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99522942 |
| 115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97672709 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97294402 |
| 117 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96495502 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96264423 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95766708 |
| 120 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95399208 |
| 121 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95294620 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94920206 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94063173 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94006894 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93047890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.34347126 |
| 2 | MP0005670_abnormal_white_adipose | 3.14998864 |
| 3 | MP0005360_urolithiasis | 3.10311166 |
| 4 | MP0005365_abnormal_bile_salt | 2.91248538 |
| 5 | MP0009840_abnormal_foam_cell | 2.72184432 |
| 6 | MP0002009_preneoplasia | 2.63851056 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.60447086 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.54237897 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.52583248 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.33088503 |
| 11 | MP0009278_abnormal_bone_marrow | 2.31742581 |
| 12 | MP0003252_abnormal_bile_duct | 2.30912868 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.20711827 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.20711827 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.13142473 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.09284390 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.09250248 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.08256712 |
| 19 | MP0004130_abnormal_muscle_cell | 2.02715212 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.01089155 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.99616086 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.92124665 |
| 23 | MP0008057_abnormal_DNA_replication | 1.87820935 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.84471868 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.75855938 |
| 26 | MP0003303_peritoneal_inflammation | 1.69318061 |
| 27 | MP0000609_abnormal_liver_physiology | 1.67855406 |
| 28 | MP0005409_darkened_coat_color | 1.66538580 |
| 29 | MP0003828_pulmonary_edema | 1.65332395 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.64697220 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.62097554 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.61515948 |
| 33 | MP0004510_myositis | 1.60856984 |
| 34 | MP0004381_abnormal_hair_follicle | 1.60433121 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.59722632 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.57334211 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.56732094 |
| 38 | MP0000383_abnormal_hair_follicle | 1.56075175 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.55139338 |
| 40 | MP0003195_calcinosis | 1.51116835 |
| 41 | MP0002796_impaired_skin_barrier | 1.48557124 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.47349716 |
| 43 | MP0005451_abnormal_body_composition | 1.42856466 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.40831198 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.40448086 |
| 46 | MP0003436_decreased_susceptibility_to | 1.33596265 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.29864346 |
| 48 | MP0005083_abnormal_biliary_tract | 1.27376178 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27134467 |
| 50 | MP0002254_reproductive_system_inflammat | 1.26871464 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.25745997 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.25187942 |
| 53 | MP0003045_fibrosis | 1.20374644 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.20127872 |
| 55 | MP0002419_abnormal_innate_immunity | 1.19274904 |
| 56 | MP0002971_abnormal_brown_adipose | 1.18370565 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.17805807 |
| 58 | MP0001661_extended_life_span | 1.16492988 |
| 59 | MP0002405_respiratory_system_inflammati | 1.15013067 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.14798990 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.14053252 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.13174552 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.11787114 |
| 64 | MP0003646_muscle_fatigue | 1.10657559 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.09193131 |
| 66 | MP0001819_abnormal_immune_cell | 1.08722584 |
| 67 | MP0002928_abnormal_bile_duct | 1.08060497 |
| 68 | MP0004087_abnormal_muscle_fiber | 1.07827036 |
| 69 | MP0005310_abnormal_salivary_gland | 1.07076944 |
| 70 | MP0004947_skin_inflammation | 1.06991154 |
| 71 | MP0009115_abnormal_fat_cell | 1.05766411 |
| 72 | MP0001800_abnormal_humoral_immune | 1.05092948 |
| 73 | MP0002006_tumorigenesis | 1.04828964 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.04488778 |
| 75 | MP0001873_stomach_inflammation | 1.04410274 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.04220829 |
| 77 | MP0003075_altered_response_to | 1.04184410 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.03851925 |
| 79 | MP0000685_abnormal_immune_system | 1.03676223 |
| 80 | MP0000598_abnormal_liver_morphology | 0.99816704 |
| 81 | MP0010307_abnormal_tumor_latency | 0.99596235 |
| 82 | MP0005330_cardiomyopathy | 0.99045575 |
| 83 | MP0000716_abnormal_immune_system | 0.95642938 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.94545519 |
| 85 | MP0001851_eye_inflammation | 0.94362647 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.93861921 |
| 87 | MP0001216_abnormal_epidermal_layer | 0.93520583 |
| 88 | MP0005334_abnormal_fat_pad | 0.92386973 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.92332924 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.92058426 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.91227309 |
| 92 | MP0002452_abnormal_antigen_presenting | 0.90999670 |
| 93 | MP0005025_abnormal_response_to | 0.90834439 |
| 94 | MP0005647_abnormal_sex_gland | 0.89878728 |
| 95 | MP0008469_abnormal_protein_level | 0.89334060 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.88460723 |
| 97 | MP0001790_abnormal_immune_system | 0.88448940 |
| 98 | MP0005387_immune_system_phenotype | 0.88448940 |
| 99 | MP0001849_ear_inflammation | 0.88307198 |
| 100 | MP0002132_abnormal_respiratory_system | 0.87618711 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.87285433 |
| 102 | MP0002269_muscular_atrophy | 0.86514549 |
| 103 | MP0005671_abnormal_response_to | 0.86408254 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.84777683 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.84690718 |
| 106 | MP0009931_abnormal_skin_appearance | 0.84669501 |
| 107 | MP0008995_early_reproductive_senescence | 0.84347067 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.84090073 |
| 109 | MP0000751_myopathy | 0.82940640 |
| 110 | MP0002429_abnormal_blood_cell | 0.82147559 |
| 111 | MP0002398_abnormal_bone_marrow | 0.82076149 |
| 112 | MP0002933_joint_inflammation | 0.82063541 |
| 113 | MP0009763_increased_sensitivity_to | 0.81958920 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.81577443 |
| 115 | MP0003724_increased_susceptibility_to | 0.81168424 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.81039913 |
| 117 | MP0005385_cardiovascular_system_phenoty | 0.80652407 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.80652407 |
| 119 | MP0000371_diluted_coat_color | 0.79991558 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.79620581 |
| 121 | MP0002722_abnormal_immune_system | 0.78780616 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.78344762 |
| 123 | MP0005275_abnormal_skin_tensile | 0.78129126 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.78107040 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.77900400 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.77509299 |
| 127 | MP0005332_abnormal_amino_acid | 0.76917512 |
| 128 | MP0009764_decreased_sensitivity_to | 0.76761753 |
| 129 | MP0005023_abnormal_wound_healing | 0.76274627 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.75651973 |
| 131 | MP0001915_intracranial_hemorrhage | 0.75320708 |
| 132 | MP0002723_abnormal_immune_serum | 0.75284294 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.74345086 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.73582443 |
| 135 | MP0002060_abnormal_skin_morphology | 0.72704975 |
| 136 | MP0001853_heart_inflammation | 0.72225834 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71457828 |
| 138 | MP0002086_abnormal_extraembryonic_tissu | 0.71305633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the nasal septum (HP:0000419) | 3.49270276 |
| 2 | Lip pit (HP:0100267) | 3.44298879 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.41751525 |
| 4 | Acute myeloid leukemia (HP:0004808) | 3.14343744 |
| 5 | Genetic anticipation (HP:0003743) | 3.09644548 |
| 6 | Complement deficiency (HP:0004431) | 3.08705090 |
| 7 | Urethral obstruction (HP:0000796) | 2.93736480 |
| 8 | Cerebral aneurysm (HP:0004944) | 2.90120310 |
| 9 | Myocardial infarction (HP:0001658) | 2.85859918 |
| 10 | Abnormality of secondary sexual hair (HP:0009888) | 2.80550647 |
| 11 | Abnormality of the axillary hair (HP:0100134) | 2.80550647 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 2.79937487 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 2.74512491 |
| 14 | Periodontitis (HP:0000704) | 2.71616826 |
| 15 | Deep venous thrombosis (HP:0002625) | 2.71162870 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 2.67745248 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 2.64024947 |
| 18 | Increased connective tissue (HP:0009025) | 2.62882782 |
| 19 | Xanthomatosis (HP:0000991) | 2.59928788 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 2.52557952 |
| 21 | Abnormality of the columella (HP:0009929) | 2.47879472 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47563447 |
| 23 | Pustule (HP:0200039) | 2.46788984 |
| 24 | Hypercholesterolemia (HP:0003124) | 2.43388271 |
| 25 | Abnormality of complement system (HP:0005339) | 2.41865123 |
| 26 | Hyperglycinuria (HP:0003108) | 2.40515066 |
| 27 | Hematochezia (HP:0002573) | 2.38979485 |
| 28 | Ventricular tachycardia (HP:0004756) | 2.37544917 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36284742 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.34963913 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33883707 |
| 32 | Increased IgE level (HP:0003212) | 2.32990101 |
| 33 | Hyperkalemia (HP:0002153) | 2.31921462 |
| 34 | Polycythemia (HP:0001901) | 2.29899314 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.29706283 |
| 36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28530910 |
| 37 | Submucous cleft hard palate (HP:0000176) | 2.28132540 |
| 38 | Dysmetric saccades (HP:0000641) | 2.26929442 |
| 39 | Glomerulonephritis (HP:0000099) | 2.25578696 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.25215352 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24450532 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24450532 |
| 43 | Atrioventricular block (HP:0001678) | 2.24157820 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.22415233 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.21966054 |
| 46 | Abnormal platelet function (HP:0011869) | 2.21966054 |
| 47 | Toxemia of pregnancy (HP:0100603) | 2.19633199 |
| 48 | Intrahepatic cholestasis (HP:0001406) | 2.18975549 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.17825812 |
| 50 | Esophageal varix (HP:0002040) | 2.16854459 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.14880545 |
| 52 | Neonatal hypoglycemia (HP:0001998) | 2.14511888 |
| 53 | Gingival bleeding (HP:0000225) | 2.13067563 |
| 54 | Ureteral obstruction (HP:0006000) | 2.12905846 |
| 55 | Long eyelashes (HP:0000527) | 2.11493831 |
| 56 | Fair hair (HP:0002286) | 2.10756639 |
| 57 | Broad metatarsal (HP:0001783) | 2.10624473 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.09983066 |
| 59 | Ketosis (HP:0001946) | 2.09157494 |
| 60 | Sparse lateral eyebrow (HP:0005338) | 2.08807160 |
| 61 | Persistence of primary teeth (HP:0006335) | 2.08153293 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.07586382 |
| 63 | Aneurysm (HP:0002617) | 2.06738988 |
| 64 | Anal stenosis (HP:0002025) | 2.06154364 |
| 65 | Colitis (HP:0002583) | 2.05348034 |
| 66 | Acute lymphatic leukemia (HP:0006721) | 2.05065522 |
| 67 | Duplicated collecting system (HP:0000081) | 2.04827753 |
| 68 | Abnormality of the renal collecting system (HP:0004742) | 2.04723860 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.03901931 |
| 70 | Macroorchidism (HP:0000053) | 2.03428340 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 2.03410326 |
| 72 | Fatigue (HP:0012378) | 2.03350308 |
| 73 | Bundle branch block (HP:0011710) | 2.02286861 |
| 74 | Hyperammonemia (HP:0001987) | 2.02281459 |
| 75 | Sudden death (HP:0001699) | 2.02016998 |
| 76 | Epistaxis (HP:0000421) | 2.00095401 |
| 77 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99867806 |
| 78 | Nephritis (HP:0000123) | 1.98661005 |
| 79 | Reticulocytosis (HP:0001923) | 1.98347716 |
| 80 | Axonal loss (HP:0003447) | 1.96973137 |
| 81 | Recurrent fungal infections (HP:0002841) | 1.95987816 |
| 82 | Decreased circulating renin level (HP:0003351) | 1.95080421 |
| 83 | Gingivitis (HP:0000230) | 1.94819556 |
| 84 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.94759473 |
| 85 | Subaortic stenosis (HP:0001682) | 1.94759473 |
| 86 | Ureteral stenosis (HP:0000071) | 1.94759090 |
| 87 | Hyperglycinemia (HP:0002154) | 1.94496229 |
| 88 | Joint hemorrhage (HP:0005261) | 1.94334731 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.93177420 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 1.93177420 |
| 91 | Recurrent viral infections (HP:0004429) | 1.92789658 |
| 92 | Malnutrition (HP:0004395) | 1.92439242 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91749472 |
| 94 | Hamartoma of the eye (HP:0010568) | 1.89799411 |
| 95 | Hypolipoproteinemia (HP:0010981) | 1.89558308 |
| 96 | Alopecia of scalp (HP:0002293) | 1.89477889 |
| 97 | Abnormality of the thoracic spine (HP:0100711) | 1.89059550 |
| 98 | Epidermoid cyst (HP:0200040) | 1.88888370 |
| 99 | Viral hepatitis (HP:0006562) | 1.88842025 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.88246730 |
| 101 | Facial diplegia (HP:0001349) | 1.88200706 |
| 102 | Prostate neoplasm (HP:0100787) | 1.87782616 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.87133762 |
| 104 | Thoracic kyphosis (HP:0002942) | 1.86538697 |
| 105 | Recurrent skin infections (HP:0001581) | 1.84162903 |
| 106 | Arterial thrombosis (HP:0004420) | 1.83893039 |
| 107 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83408097 |
| 108 | Acanthocytosis (HP:0001927) | 1.82615542 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82175859 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82175859 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82175859 |
| 112 | Generalized hypopigmentation of hair (HP:0011358) | 1.82137762 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.82100420 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82100420 |
| 115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81503200 |
| 116 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80920944 |
| 117 | Coarse hair (HP:0002208) | 1.80395975 |
| 118 | Advanced eruption of teeth (HP:0006288) | 1.80124783 |
| 119 | Ectropion (HP:0000656) | 1.79460962 |
| 120 | Broad face (HP:0000283) | 1.79339811 |
| 121 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.79243560 |
| 122 | Ventricular arrhythmia (HP:0004308) | 1.79025791 |
| 123 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.78755027 |
| 124 | Heart block (HP:0012722) | 1.78636985 |
| 125 | Cellulitis (HP:0100658) | 1.77935303 |
| 126 | Poikilocytosis (HP:0004447) | 1.77718590 |
| 127 | Dislocated radial head (HP:0003083) | 1.76758146 |
| 128 | Hyperglycemia (HP:0003074) | 1.76313190 |
| 129 | Global brain atrophy (HP:0002283) | 1.76219904 |
| 130 | Prominent nose (HP:0000448) | 1.76174026 |
| 131 | Abnormality of T cell physiology (HP:0011840) | 1.75989762 |
| 132 | Clumsiness (HP:0002312) | 1.75650304 |
| 133 | Thick nail (HP:0001805) | 1.74981864 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74467409 |
| 135 | Skin nodule (HP:0200036) | 1.74275787 |
| 136 | Upper motor neuron abnormality (HP:0002127) | 1.73407843 |
| 137 | Neonatal death (HP:0003811) | 1.72727411 |
| 138 | Truncal obesity (HP:0001956) | 1.71392761 |
| 139 | Sandal gap (HP:0001852) | 1.71240581 |
| 140 | Difficulty running (HP:0009046) | 1.70617152 |
| 141 | Enlarged penis (HP:0000040) | 1.70415672 |
| 142 | Pigmentary retinal degeneration (HP:0001146) | 1.69519778 |
| 143 | Distal lower limb amyotrophy (HP:0008944) | 1.69317499 |
| 144 | Narrow palate (HP:0000189) | 1.68705597 |
| 145 | Flat acetabular roof (HP:0003180) | 1.67965978 |
| 146 | Hyporeflexia of lower limbs (HP:0002600) | 1.67965454 |
| 147 | Germ cell neoplasia (HP:0100728) | 1.67848815 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.67513958 |
| 149 | Chronic diarrhea (HP:0002028) | 1.67503179 |
| 150 | Abnormal atrioventricular conduction (HP:0005150) | 1.67375904 |
| 151 | Distal lower limb muscle weakness (HP:0009053) | 1.66180822 |
| 152 | Oligodontia (HP:0000677) | 1.65478995 |
| 153 | Increased serum ferritin (HP:0003281) | 1.65395742 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.65386825 |
| 155 | Difficulty climbing stairs (HP:0003551) | 1.65383598 |
| 156 | Exercise-induced myalgia (HP:0003738) | 1.65033331 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.65031098 |
| 158 | Abnormality of iron homeostasis (HP:0011031) | 1.64909123 |
| 159 | Myoglobinuria (HP:0002913) | 1.64523175 |
| 160 | Depressed nasal tip (HP:0000437) | 1.64522771 |
| 161 | Palmoplantar hyperkeratosis (HP:0000972) | 1.64425837 |
| 162 | Osteolytic defects of the hand bones (HP:0009699) | 1.63528989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.26991715 |
| 2 | RIPK1 | 3.09528278 |
| 3 | CAMK1D | 3.04470425 |
| 4 | CDK12 | 2.87358581 |
| 5 | PKN2 | 2.70612214 |
| 6 | TRIB3 | 2.65960320 |
| 7 | TAOK3 | 2.57733636 |
| 8 | CAMK1G | 2.48687604 |
| 9 | MAP3K10 | 2.40549878 |
| 10 | SIK1 | 2.30939920 |
| 11 | MAP4K1 | 2.29624033 |
| 12 | LATS1 | 1.95417858 |
| 13 | TYK2 | 1.69644966 |
| 14 | TGFBR2 | 1.69381117 |
| 15 | PTK6 | 1.65873544 |
| 16 | TTN | 1.64676841 |
| 17 | EEF2K | 1.61626069 |
| 18 | BLK | 1.57901100 |
| 19 | PRKAA2 | 1.52210265 |
| 20 | ACVR1B | 1.50874625 |
| 21 | RIPK4 | 1.50272827 |
| 22 | JAK1 | 1.39925734 |
| 23 | PIK3CG | 1.38680362 |
| 24 | MAP3K7 | 1.34262641 |
| 25 | HIPK2 | 1.30904438 |
| 26 | STK3 | 1.27898931 |
| 27 | FLT3 | 1.27174780 |
| 28 | PRPF4B | 1.26689580 |
| 29 | KIT | 1.25920962 |
| 30 | DMPK | 1.20565754 |
| 31 | SMG1 | 1.18890753 |
| 32 | NLK | 1.18756356 |
| 33 | IRAK3 | 1.17669432 |
| 34 | MAP2K3 | 1.16901349 |
| 35 | MAP3K2 | 1.16403338 |
| 36 | BRD4 | 1.16096446 |
| 37 | STK38 | 1.12857796 |
| 38 | MAP3K13 | 1.11115257 |
| 39 | SIK2 | 1.10258979 |
| 40 | MTOR | 1.07951279 |
| 41 | PIK3CA | 1.07253446 |
| 42 | CDK6 | 1.07035649 |
| 43 | SGK3 | 1.06991344 |
| 44 | INSRR | 1.04641680 |
| 45 | MELK | 1.03643395 |
| 46 | CDK4 | 1.02557636 |
| 47 | WNK1 | 1.00610074 |
| 48 | CSF1R | 1.00294706 |
| 49 | TAOK1 | 0.99919915 |
| 50 | FGFR4 | 0.98406943 |
| 51 | MAPKAPK3 | 0.98124080 |
| 52 | STK10 | 0.97585095 |
| 53 | ITK | 0.94165739 |
| 54 | JAK2 | 0.93401714 |
| 55 | FER | 0.93275426 |
| 56 | BCKDK | 0.92656416 |
| 57 | ZAP70 | 0.91459291 |
| 58 | MAPK11 | 0.91197171 |
| 59 | RPS6KB2 | 0.90692843 |
| 60 | HCK | 0.89649541 |
| 61 | NEK2 | 0.87575167 |
| 62 | MAP3K1 | 0.86498474 |
| 63 | CSK | 0.84201750 |
| 64 | TBK1 | 0.82792750 |
| 65 | TNK2 | 0.82565374 |
| 66 | MAP3K3 | 0.82258658 |
| 67 | CAMK4 | 0.82048316 |
| 68 | MATK | 0.81617005 |
| 69 | PRKAA1 | 0.81239356 |
| 70 | MARK2 | 0.79896726 |
| 71 | TXK | 0.78861671 |
| 72 | JAK3 | 0.78516765 |
| 73 | MST1R | 0.78253876 |
| 74 | ICK | 0.77796379 |
| 75 | MAP3K14 | 0.77634974 |
| 76 | FGFR3 | 0.75153374 |
| 77 | BTK | 0.75070597 |
| 78 | STK4 | 0.74894159 |
| 79 | MAP2K6 | 0.72885194 |
| 80 | CHUK | 0.71174290 |
| 81 | EPHA2 | 0.68792210 |
| 82 | IRAK1 | 0.68500059 |
| 83 | FES | 0.66582513 |
| 84 | CAMK1 | 0.65107018 |
| 85 | STK39 | 0.64405249 |
| 86 | PIM1 | 0.61201544 |
| 87 | CDK9 | 0.61059762 |
| 88 | EPHB1 | 0.60912296 |
| 89 | MAPK12 | 0.60499707 |
| 90 | LCK | 0.60428626 |
| 91 | BMX | 0.60277351 |
| 92 | GRK6 | 0.59590520 |
| 93 | RPS6KA6 | 0.59511799 |
| 94 | SGK2 | 0.58801925 |
| 95 | WNK4 | 0.57912886 |
| 96 | RPS6KL1 | 0.57661370 |
| 97 | PDGFRB | 0.57188727 |
| 98 | MAPK3 | 0.57036372 |
| 99 | PRKD1 | 0.55027981 |
| 100 | PDGFRA | 0.55015156 |
| 101 | IKBKE | 0.53527478 |
| 102 | PDK1 | 0.52896207 |
| 103 | EPHA3 | 0.52544819 |
| 104 | MAP2K2 | 0.51804965 |
| 105 | STK24 | 0.51174210 |
| 106 | DAPK2 | 0.50980490 |
| 107 | MAPK1 | 0.50187564 |
| 108 | CDC42BPA | 0.50079050 |
| 109 | TRPM7 | 0.49853318 |
| 110 | ALK | 0.49648009 |
| 111 | PTK2 | 0.48900725 |
| 112 | PRKD2 | 0.48786095 |
| 113 | IKBKB | 0.48571605 |
| 114 | BMPR2 | 0.47898581 |
| 115 | MAPK7 | 0.47405702 |
| 116 | TIE1 | 0.46858780 |
| 117 | FRK | 0.46223594 |
| 118 | TEC | 0.46052343 |
| 119 | MKNK2 | 0.45773110 |
| 120 | PDPK1 | 0.44584297 |
| 121 | KDR | 0.43927358 |
| 122 | LMTK2 | 0.43800195 |
| 123 | CAMKK1 | 0.43666394 |
| 124 | AKT3 | 0.42894704 |
| 125 | ZAK | 0.42509464 |
| 126 | SCYL2 | 0.42028435 |
| 127 | MAP3K6 | 0.41382698 |
| 128 | LRRK2 | 0.40921206 |
| 129 | ERBB2 | 0.40507752 |
| 130 | SYK | 0.40394769 |
| 131 | PINK1 | 0.40121455 |
| 132 | RPS6KC1 | 0.40001052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.87615787 |
| 2 | Lysine degradation_Homo sapiens_hsa00310 | 2.66739226 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26458353 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20638710 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20414021 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10490193 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07308612 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01457178 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95678802 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85476161 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79445287 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79257805 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.74193670 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65368617 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61283104 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41389590 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.39674105 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38143293 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.38027618 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35166058 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32499617 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.30226257 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30175308 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29208448 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27617785 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26317294 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26073157 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.23304062 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22811926 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19750435 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18854551 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18554247 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18302474 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16896772 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11877309 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11843470 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.08477882 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06463070 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05711926 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05247785 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05240674 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05097478 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03065422 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00290912 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98885199 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97679302 |
| 47 | Prostate cancer_Homo sapiens_hsa05215 | 0.97291987 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97224445 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96778942 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95225043 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95212141 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95154491 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94256583 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92609194 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.91912870 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91898149 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90206267 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89274673 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88340324 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87586154 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87559308 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86538711 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86352419 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85851688 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84926472 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84328540 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83882125 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82864636 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82504080 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82285698 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81410494 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81228689 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80011908 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.79222195 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78711407 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77988928 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.77434502 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76910844 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76081246 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76048233 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.75697640 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74418449 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73271198 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72560606 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72104561 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71808873 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71689685 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71584329 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71135342 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70230186 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69088197 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68893894 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68660807 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68486943 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66401205 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.65367541 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64998230 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64952072 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64144546 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63006876 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61756880 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.61063817 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60047930 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59911784 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59682929 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58919232 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58768274 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57947442 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57735541 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57259880 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56860661 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56714938 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56590098 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56542054 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55705945 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55154956 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54464589 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.52708665 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.52411161 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51561160 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51550271 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51216893 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.51107478 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50983419 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49967938 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49219065 |
| 127 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47765091 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47116568 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46954936 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46380990 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44625938 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44569920 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43638984 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.43515171 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42790964 |
| 136 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41374464 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40547410 |
| 138 | Hepatitis B_Homo sapiens_hsa05161 | 0.40541827 |
| 139 | Measles_Homo sapiens_hsa05162 | 0.40216647 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38792318 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38252885 |

